Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost Effectiveness and Health Impact in U.S. Populations

INTRODUCTION: Recommending both the conjugate and polysaccharide pneumococcal vaccines to all U.S. seniors may have little public health impact and be economically unreasonable. Public health impact and cost effectiveness of using both vaccines in all adults aged ≥65 years were estimated compared wi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Am J Prev Med
Prif Awduron: Wateska, Angela R., Nowalk, Mary Patricia, Lin, Chyongchiou J., Harrison, Lee H., Schaffner, William, Zimmerman, Richard K., Smith, Kenneth J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7089827/
https://ncbi.nlm.nih.gov/pubmed/32001052
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2019.10.022
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg